Kwesst Micro Systems Inc
NASDAQ:KWE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
K
|
Kwesst Micro Systems Inc
NASDAQ:KWE
|
CA |
|
N
|
NVIDIA Corp
DUS:NVD
|
US |
|
A
|
Axion Ventures Inc
OTC:AXNVF
|
CA |
|
Genpact Ltd
NYSE:G
|
BM |
|
Cullen/Frost Bankers Inc
NYSE:CFR
|
US |
|
E
|
ExaWizards Inc
TSE:4259
|
JP |
|
Panorama Sentrawisata Tbk PT
IDX:PANR
|
ID |
|
V
|
Vital Healthcare Property Trust
NZX:VHP
|
NZ |
|
G
|
Glencore PLC
JSE:GLN
|
CH |
|
Chiba Bank Ltd
TSE:8331
|
JP |
|
L
|
Lithos Energy Ltd
CNSX:LITS
|
CA |
|
Neoen SA
PAR:NEOEN
|
FR |
|
P
|
Partron Co Ltd
KOSDAQ:091700
|
KR |
|
E
|
EPIC Acquisition Corp
AEX:EPIC
|
UK |
|
UK Commercial Property REIT Ltd
LSE:UKCM
|
GG |
|
Shenzhen INVT Electric Co Ltd
SZSE:002334
|
CN |
|
X
|
Xavi Technologies Corp
TWSE:3447
|
TW |
|
N
|
Novita SA
WSE:NVT
|
PL |
|
I
|
Isoenergy Ltd
SWB:I01
|
CA |
|
Webuild SpA
MIL:WBD
|
IT |
|
Innovaderma PLC
LSE:IDP
|
UK |
|
C
|
Corentec Co Ltd
KOSDAQ:104540
|
KR |
|
BRF SA
NYSE:BRFS
|
BR |
|
L'Oreal SA
PAR:OR
|
FR |
Income Statement
Earnings Waterfall
Kwesst Micro Systems Inc
Income Statement
Kwesst Micro Systems Inc
| Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Revenue |
1
N/A
|
1
-10%
|
1
-24%
|
1
-28%
|
1
+14%
|
1
+43%
|
1
-1%
|
1
-13%
|
1
+39%
|
1
-15%
|
1
+31%
|
2
+13%
|
2
-3%
|
2
+50%
|
3
+34%
|
|
| Gross Profit | ||||||||||||||||
| Cost of Revenue |
(1)
|
(1)
|
(1)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(1)
|
(1)
|
(2)
|
|
| Gross Profit |
0
N/A
|
0
-17%
|
0
-25%
|
0
+40%
|
0
-57%
|
0
+100%
|
0
+3%
|
0
N/A
|
(0)
N/A
|
(0)
-121%
|
(0)
+50%
|
(0)
+0%
|
0
N/A
|
1
+94%
|
1
+8%
|
|
| Operating Income | ||||||||||||||||
| Operating Expenses |
(10)
|
(11)
|
(11)
|
(11)
|
(10)
|
(9)
|
(10)
|
(10)
|
(12)
|
(13)
|
(13)
|
(12)
|
(10)
|
(11)
|
(10)
|
|
| Selling, General & Administrative |
(7)
|
(14)
|
(14)
|
(14)
|
(8)
|
(7)
|
(8)
|
(9)
|
(9)
|
(11)
|
(10)
|
(9)
|
(7)
|
(9)
|
(8)
|
|
| Research & Development |
(2)
|
(3)
|
(3)
|
(3)
|
(2)
|
(2)
|
(1)
|
(1)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(3)
|
(2)
|
|
| Depreciation & Amortization |
(0)
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(1)
|
0
|
0
|
0
|
(1)
|
0
|
(0)
|
|
| Other Operating Expenses |
0
|
6
|
6
|
6
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Operating Income |
(9)
N/A
|
(11)
-18%
|
(11)
+0%
|
(11)
+1%
|
(10)
+6%
|
(8)
+17%
|
(9)
-10%
|
(10)
-5%
|
(12)
-24%
|
(13)
-8%
|
(13)
+1%
|
(12)
+6%
|
(10)
+20%
|
(10)
-4%
|
(9)
+12%
|
|
| Pre-Tax Income | ||||||||||||||||
| Interest Income Expense |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
0
|
|
| Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
0
|
0
|
0
|
(0)
|
0
|
0
|
|
| Total Other Income |
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
2
|
1
|
4
|
6
|
3
|
5
|
2
|
(0)
|
0
|
|
| Pre-Tax Income |
(9)
N/A
|
(11)
-18%
|
(11)
0%
|
(11)
+0%
|
(11)
+4%
|
(10)
+10%
|
(8)
+11%
|
(9)
-10%
|
(9)
+0%
|
(7)
+19%
|
(10)
-31%
|
(8)
+23%
|
(7)
+1%
|
(10)
-41%
|
(8)
+20%
|
|
| Net Income | ||||||||||||||||
| Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Income from Continuing Operations |
(9)
|
(11)
|
(11)
|
(11)
|
(11)
|
(9)
|
(8)
|
(9)
|
(9)
|
(7)
|
(10)
|
(8)
|
(7)
|
(10)
|
(8)
|
|
| Net Income (Common) |
(9)
N/A
|
(11)
-18%
|
(11)
0%
|
(11)
+0%
|
(11)
+4%
|
(9)
+10%
|
(8)
+11%
|
(9)
-10%
|
(9)
0%
|
(7)
+19%
|
(10)
-31%
|
(8)
+23%
|
(7)
+1%
|
(10)
-41%
|
(8)
+20%
|
|
| EPS (Diluted) |
-3 096.34
N/A
|
-3 312.31
-7%
|
-3 256.63
+2%
|
-3 110.16
+4%
|
-3 022.98
+3%
|
-1 238.9
+59%
|
-414.45
+67%
|
-456.01
-10%
|
-478.73
-5%
|
-280.29
+41%
|
-353.69
-26%
|
-179.39
+49%
|
-188.83
-5%
|
-72.69
+62%
|
-745.36
-925%
|
|